Allotment

Capital Power Announces $250 million Bought Offering of Common Shares

Retrieved on: 
Tuesday, May 25, 2021

EDMONTON, Alberta, May 25, 2021 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) (Capital Power or the Company) announced today that it has entered into an agreement with a syndicate of underwriters led by TD Securities Inc. and CIBC Capital Markets (collectively the Underwriters), pursuant to which the Underwriters have agreed to purchase on a bought deal basis, an aggregate of6,505,000 common shares of Capital Power, at an offering price of $38.45 per common share (the Offering Price) for total gross proceeds to the Company of approximately $250 million (the Offering).

Key Points: 
  • EDMONTON, Alberta, May 25, 2021 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) (Capital Power or the Company) announced today that it has entered into an agreement with a syndicate of underwriters led by TD Securities Inc. and CIBC Capital Markets (collectively the Underwriters), pursuant to which the Underwriters have agreed to purchase on a bought deal basis, an aggregate of6,505,000 common shares of Capital Power, at an offering price of $38.45 per common share (the Offering Price) for total gross proceeds to the Company of approximately $250 million (the Offering).
  • The Underwriters have also been granted an option (the Over-Allotment Option) to purchase up to an additional975,750 common shares at the Offering Price to cover over-allotments, if any.
  • If the Over-Allotment Option is exercised in full, total gross proceeds to the Company from the Offering will be approximately $288 million.
  • Capital Power owns over 6,400 MW of power generation capacity at 26 facilities across North America.

Aldel Financial Inc. Announces Closing of $115 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option

Retrieved on: 
Monday, April 12, 2021

This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 1,500,000 units.

Key Points: 
  • This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 1,500,000 units.
  • Each unit consists of one share of common stock and one-half of one redeemable warrant.
  • Each whole warrant entitles the holder thereof to purchase one share of common stock at $11.50 per share.
  • Aldel Financial Inc. undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210412005912/en/\n"

Banque Fédérative du Credit Mutuel: Stabilisation Notice

Retrieved on: 
Monday, March 29, 2021

Stabilisation period expected to start on:

Key Points: 
  • Stabilisation period expected to start on:
    Stabilisation period expected to end no later than:
    Existence, maximum size and conditions of use of over-allotment facility:
    The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.
  • However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.
  • Click on, or paste the following link into your web browser, to view the associated PDF document.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

TeraGo Announces Overnight Marketed Offering of Units

Retrieved on: 
Monday, March 22, 2021

TORONTO, March 22, 2021 (GLOBE NEWSWIRE) -- TeraGo Inc. (TeraGo or the Company) (TSX: TGO, www.terago.ca), has announced today that it has commenced an overnight marketed offering of units (the "Units") for gross proceeds of approximately $15 million (the "Offering").

Key Points: 
  • TORONTO, March 22, 2021 (GLOBE NEWSWIRE) -- TeraGo Inc. (TeraGo or the Company) (TSX: TGO, www.terago.ca), has announced today that it has commenced an overnight marketed offering of units (the "Units") for gross proceeds of approximately $15 million (the "Offering").
  • TeraGo has granted the Underwriters an over-allotment option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the total number of Units, Shares and/or Warrants or any combination thereof sold under the Offering to cover over-allotments, if any (the Over-Allotment Option).
  • The Offering will be priced in the context of the market with the price and other final terms to be determined at the time of entering into an underwriting agreement for the Offering.
  • Closing of the Offering will be subject to customary closing conditions, including listing of the Shares on the Toronto Stock Exchange and all required approvals.

Fix Price Group Ltd. : Stabilisation Notice

Retrieved on: 
Friday, March 5, 2021

Any Over-allotment GDRs made available pursuant to the Over-allotment Option will be purchased on the same terms and conditions as the GDRs being sold in the Offering.

Key Points: 
  • Any Over-allotment GDRs made available pursuant to the Over-allotment Option will be purchased on the same terms and conditions as the GDRs being sold in the Offering.
  • The Over-allotment Option may be exercised in full or in part at any time during the stabilisation period.
  • However, there is no assurance that the Stabilising Manager or any of its agents will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.
  • Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

Points International announces C$25 million bought deal financing

Retrieved on: 
Thursday, March 4, 2021

In the event that the over-allotment option is exercised in full, the gross proceeds of the Offering will be approximately $28.7 million.

Key Points: 
  • In the event that the over-allotment option is exercised in full, the gross proceeds of the Offering will be approximately $28.7 million.
  • The net proceeds may also be used to fund future growth opportunities and to accelerate the Companys business development pipeline.
  • Founded in 2000, Points is headquartered in Toronto with teams operating around the globe.
  • These statements are not historical facts but instead represent only Points expectations, estimates and projections regarding future events.

Medigus Closes $8.5 Million Underwritten Public Offering of American Depositary Shares

Retrieved on: 
Monday, March 1, 2021

OMER, Israel, March 01, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,258,438 American Depositary Shares (the ADSs).

Key Points: 
  • OMER, Israel, March 01, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 3,258,438 American Depositary Shares (the ADSs).
  • The gross proceeds to the Company from this offering are expected to be approximately $8.5 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.
  • The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
  • If the over-allotment option is exercised in full it would increase the total gross proceeds of the offering to approximately $9.7 million.

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Retrieved on: 
Friday, February 26, 2021

Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a bought deal basis, 12,750,000 common shares of Field Trip (Common Shares), at a price of C$6.50 per Common Share (the Issue Price), for aggregate gross proceeds of $82,875,000 (the Offering).

Key Points: 
  • Pursuant to the upsized deal terms, the Underwriters have agreed to purchase, on a bought deal basis, 12,750,000 common shares of Field Trip (Common Shares), at a price of C$6.50 per Common Share (the Issue Price), for aggregate gross proceeds of $82,875,000 (the Offering).
  • Field Trip intends to use the net proceeds from the Offering for the ongoing development of the FT-104 novel psychedelic development program, the opening of new Field Trip Health centers, and for working capital and general corporate purposes.
  • In the event that the Over-Allotment Option is exercised in its entirety, the aggregate gross proceeds of the Offering will be $95,306,250.
  • About Field Trip Health Ltd.
    Field Trip is the global leader in the development and delivery of psychedelic therapies.

Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

Retrieved on: 
Thursday, February 25, 2021

Field Trip intends to use the net proceeds from the Offering for the ongoing development of the FT-104 novel psychedelic development program, the opening of new Field Trip Health centers, and for working capital and general corporate purposes.

Key Points: 
  • Field Trip intends to use the net proceeds from the Offering for the ongoing development of the FT-104 novel psychedelic development program, the opening of new Field Trip Health centers, and for working capital and general corporate purposes.
  • In the event that the Over-Allotment Option is exercised in its entirety, the aggregate gross proceeds of the Offering will be $57,500,014.
  • About Field Trip Health Ltd.
    Field Trip is the global leader in the development and delivery of psychedelic therapies.
  • Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect.

Medigus Prices $8.5 Million Underwritten Public Offering of American Depositary Shares

Retrieved on: 
Thursday, February 25, 2021

OMER, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the pricing of an underwritten public offering of 3,258,438 American Depositary Shares (the ADSs).

Key Points: 
  • OMER, Israel, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the pricing of an underwritten public offering of 3,258,438 American Depositary Shares (the ADSs).
  • The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
  • If the over-allotment option is exercised in full it would increase the total gross proceeds of the offering to approximately $9.7 million.
  • For example, Medigus uses forward looking statements when describing the expected closing date of the offering and the intended use of proceeds from such offering.